Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-07-12, Stock:LLY, The news for the past five days is as follows:
2021-07-02: NEWS1: The Zacks Analyst Blog Highlights: Eli Lilly, Pfizer, BioNTech and Bayer.
2021-07-06: NEWS1: 10 Psychedelic Startups Investors are Flocking To.NEWS2: Eli Lilly, Boehringer Ingelheim Tout Heart Failure Win For Jardiance.NEWS3: Why investors are leaving work-from-home stocks behind.NEWS4: Breakthrough results for Jardiance® (empagliflozin) confirm EMPEROR-Preserved as first and only successful trial for heart failure with preserved ejection fraction.
2021-07-07: NEWS1: Lilly's (LLY) Jardiance Heart Failure Study Meets Main Goal.NEWS2: Is Eli Lilly a Better Alzheimer's Stock Than Biogen?.
2021-07-08: NEWS1: Biogen Stock Just Popped For An Odd Reason — Here's Why.NEWS2: Biogen Stock Pops Despite New FDA Limits On Alzheimer's Drug Use.NEWS3: SNY vs. LLY: Which Stock Is the Better Value Option?.NEWS4: Eli Lilly, Verge Genomics Ink $720M Pact For Amyotrophic Lateral Sclerosis Therapies.
2021-07-09: NEWS1: Eli Lilly's Mirikizumab Shows Mucosal Healing In Ulcerative Colitis Maintained For Up To One Year.NEWS2: Pharma Stock Roundup: GSK's New Deal With Alector, MRK & AZN's FDA Updates.NEWS3: Pharma Stock Roundup: GSK's New Deal With Alector, MRK & AZN's FDA Updates.NEWS4: Mirikizumab Up-Regulates Genes Associated with Mucosal Healing in Ulcerative Colitis for Up to One Year in Phase 2 Study.

Answer: Rise